HepaRegeniX raises 15 million euros in Series C financing round
Funds to support the HRX-215 Phase Ib clinical trial in the US and an international multicenter Phase IIa clinical trial for liver regeneration Elias Papatheodorou...
HepaRegeniX raises €15 million in Series C funding round to advance clinical development of HRX-215 for liver regeneration
HepaRegeniX GmbH Funds to support the HRX-215 Phase Ib clinical trial in the US and an international multicenter Phase IIa clinical trial for liver regeneration...
